Market Value1,372,864,097
Total Holdings61
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RYTM / Rhythm Pharmaceuticals, Inc.
ACHV / Achieve Life Sciences, Inc.
ELVN / Enliven Therapeutics, Inc.
ALKS / Alkermes plc
NXTC / NextCure, Inc.
ATXS / Astria Therapeutics, Inc.
INSM / Insmed Incorporated
IDYA / IDEAYA Biosciences, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
SLNO / Soleno Therapeutics, Inc. Put
SLNO / Soleno Therapeutics, Inc.
RAPP / Rapport Therapeutics, Inc.
SYK / Stryker Corporation
RNA / Avidity Biosciences, Inc.
ESTA / Establishment Labs Holdings Inc.
IKNA / Ikena Oncology, Inc.
BDX / Becton, Dickinson and Company
ALNY / Alnylam Pharmaceuticals, Inc.
TMO / Thermo Fisher Scientific Inc.
JAZZ / Jazz Pharmaceuticals plc
ISRG / Intuitive Surgical, Inc.
SRPT / Sarepta Therapeutics, Inc.
NTRA / Natera, Inc.
KURA / Kura Oncology, Inc.
GILD / Gilead Sciences, Inc.
TGTX / TG Therapeutics, Inc.
BIOA / BioAge Labs, Inc.
RVMD / Revolution Medicines, Inc.
CATX / Perspective Therapeutics, Inc.
IMTXW / Immatics N.V. - Equity Warrant
DXCM / DexCom, Inc.
COGT / Cogent Biosciences, Inc.
IMNM / Immunome, Inc.
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
EW / Edwards Lifesciences Corporation
ANAB / AnaptysBio, Inc.
REPL / Replimune Group, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
ERAS / Erasca, Inc.
ILMN / Illumina, Inc.
JANX / Janux Therapeutics, Inc.
IRON / Disc Medicine, Inc.
BSX / Boston Scientific Corporation
VIR / Vir Biotechnology, Inc.
NARI / Inari Medical, Inc.
INBX / Inhibrx Biosciences, Inc.
VERA / Vera Therapeutics, Inc.
ICUI / ICU Medical, Inc.
SVRA / Savara Inc.
ABBV / AbbVie Inc.
AVBP / ArriVent BioPharma, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
PHVS / Pharvaris N.V.
EXAS / Exact Sciences Corporation
CABA / Cabaletta Bio, Inc.
KROS / Keros Therapeutics, Inc.
GH / Guardant Health, Inc.
LLY / Eli Lilly and Company
INCY / Incyte Corporation
DHR / Danaher Corporation
NVS / Novartis AG - Depositary Receipt (Common Stock) Put
MRNS / Marinus Pharmaceuticals, Inc.
LUNG / Pulmonx Corporation
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
IMTX / Immatics N.V.
PAHC / Phibro Animal Health Corporation
TVTX / Travere Therapeutics, Inc.
ELAN / Elanco Animal Health Incorporated
INZY / Inozyme Pharma, Inc.
AVTR / Avantor, Inc.
AVTE / Aerovate Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc. Put
AXSM / Axsome Therapeutics, Inc. Call
GMED / Globus Medical, Inc.
BOLT / Bolt Biotherapeutics, Inc.